Ethinylestradiol/Drospirenone

@article{Keam2003EthinylestradiolDrospirenone,
  title={Ethinylestradiol/Drospirenone},
  author={S. Keam and A. Wagstaff},
  journal={Treatments in Endocrinology},
  year={2003},
  volume={2},
  pages={49-70}
}
SummaryAbstractEthinylestradiol 30μg/drospirenone 3mg (Yasmin®1, petibelle®) [EE/DRSP] is a combined contraceptive pill (CC) for the prevention of pregnancy in women of reproductive age. Drospirenone is a novel progestogen with antimineralocorticoid, progestogenic and antiandrogenic activity.The theoretical (0–0.07) and corrected (0.41–0.71) Pearl indices and pregnancy ratios (0.3–0.84) in young, healthy women aged 18–35 years (or 18–30 years if smokers) given 13–26 cycles of EE/DRSP in large… Expand
View on Springer
13 Citations
Highly Influential Citations
1
Background Citations
3
Results Citations
1

13 Citations

Citation Type

Citation Type

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen)
Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
  • H. Blode, K. Kowal, Katrin Roth, S. Reif
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2012
A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
Sexual behavior and oral contraception: a pilot study.
ORIGINAL RESEARCH—WOMEN'S SEXUAL HEALTH
Ethinyl Estradiol/Drospirenone for the Treatment of the Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder
Oral contraceptives : Does formulation matter ? OCs come in a variety of formulations
Electrochemical immunosensor for ethinylestradiol using diazonium salt grafting onto silver nanoparticles-silica-graphene oxide hybrids.
A novel and sensitive method for ethinylestradiol quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry: application to a comparative pharmacokinetics study.
A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry.
...
1
2
...

References

SHOWING 1-10 OF 62 REFERENCES
Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone
  • J. Huber, J. Foidart, +5 authors R. Heithecker
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2000
Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol
  • P. Rosenbaum, W. Schmidt, +7 authors R. Heithecker
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2000
A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel.
Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers
...
1
2
3
4
5
...